Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments
Posted inAlternative and Complementary Medicine Biotechnology and Bioengineering Clinical Trials Drugs (Pharmaceuticals) Dystonia Food and Drug Administration Health and Human Services Department Kennedy, Robert F Jr National Institutes of Health Regulation and Deregulation of Industry Stem Cells Therapy and Rehabilitation Trump, Donald J United States Politics and Government

Kennedy Says ‘Charlatans’ Are No Reason to Block Unproven Stem Cell Treatments

The U.S. health secretary said people should have access to experimental therapies including unregulated stem cells. But some methods have resulted in blindness, tumors and other injuries.
Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug
Posted inClinical Trials CVS Caremark Corporation Drugs (Pharmaceuticals) Eli Lilly and Company GLP-1 RAs (Drug) Health Insurance and Managed Care Novo Nordisk A/S Obesity Prices (Fares, Fees and Rates) Research Weight

Why Patients Are Being Forced to Switch to a 2nd-Choice Obesity Drug

CVS Caremark decided to stop offering Zepbound in favor of Wegovy for weight loss. It’s the latest example of limits imposed by insurance that disrupt treatments for patients.
Kennedy Issues Demands for Vaccine Approvals that Could Affect Fall Covid Boosters
Posted inClinical Trials Coronavirus (2019-nCoV) Drugs (Pharmaceuticals) Immune System Kennedy, Robert F Jr Marks, Peter W Medicine and Health Placebos Regulation and Deregulation of Industry RNA (Ribonucleic Acid) Rumors and Misinformation Tests (Medical) Trump, Donald J Vaccination and Immunization

Kennedy Issues Demands for Vaccine Approvals that Could Affect Fall Covid Boosters

The agency suggested that clinical trials in humans may be required for updated Covid shots, raising questions about whether they will be available in the fall.